Get started
Author

Sudha Rani Myneni

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 · Michele Vacca, Ioannis Kamzolas, et al. · Nature Metabolism · 255
PDF
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
2023 · Ferenc E Mózes, Jenny A Lee, et al. · ˜The œLancet. Gastroenterology & hepatology · 209
PDF
Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort
2025 · Vlad Ratziu, Rambabu Surabattula, et al. · Gut · 12
PDF
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study
2026 · Michael Pavlides, Yasaman Vali, et al. · Nature Medicine · 8
PDF
WED-213 Hepatic antifibrotic response by fibrogenesis markers in patients with MASLD undergoing a 6-month randomized dietary trial
2026 · Angelo Armandi, Lorenza Vaira, et al. · Journal of Hepatology
FRI-323 Matricellular serum biomarkers predict fibrosis severity and clinical outcomes in autoimmune hepatitis and primary biliary cholangitis
2026 · Ludwig Horst, Rambabu Surabattula, et al. · Journal of Hepatology
WED-382-YI Thrombospondin-2, a direct serum marker of fibrogenesis, to assess treatment response in MASLD in a 6-month lifestyle intervention program
2025 · Angelo Armandi, Rambabu Surabattula, et al. · Journal of Hepatology
FRI-425 Thrombospondin-2 reflects improved metabolism and attenuated liver fibrogenesis in severely obese patients undergoing an intensive weight-loss therapy
2025 · Rambabu Surabattula, Nathalie Rohmann, et al. · Journal of Hepatology
THU-066 Femoral vs hepatic vein plasma levels of collagen biomarkers confirm Pro-C3 as true marker of collagen synthesis in the fibrotic/cirrhotic liver
2025 · Rambabu Surabattula, Troels Busk, et al. · Journal of Hepatology
THU-260 Serum thrombospondin-2 and insulin -like growth factor binding protein 7 predict liver fibrosis and fibrosis regression in patients with MASLD post bariatric surgery
2024 · Rambabu Surabattula, Pierre Bel Lassen, et al. · Journal of Hepatology
WED-021 Circulating thrombospondin-2 as a novel, highly predictive serum marker of liver fibrosis progression post liver transplant
2024 · Rambabu Surabattula, Sudha Rani Myneni, et al. · Journal of Hepatology
Su1545 SERUM THROMBOSPONDIN (TSP2) AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 7 (IGFBP7) PREDICT LIVER FIBROSIS, FIBROGENESIS AND REGRESSION IN MAFLD PATIENTS UNDERGOING BARIATRIC SURGERY
2024 · Rambabu Surabattula, Pierre Bel Lassen, et al. · Gastroenterology
Mo1607 NOVEL MATRICELLULAR SERUM FIBROSIS MARKER THROMBOSPONDIN-2 (TSP2) PREDICTS LIVER FIBROSIS AND FIBROGENESIS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
2024 · Rambabu Surabattula, Ludwig J Horst, et al. · Gastroenterology
Serum GLP-1 and Thrombospondin-2 predict improved metabolism and attenuated liver fibrogenesis in severely obese patients undergoing an intensive weight loss (Kiel Intervention Cohort)
2024 · Julia Koppenhagen, Rambabu Surabattula, et al. · Diabetologie und Stoffwechsel
Thrombospondin-2 as a new biomarker for at risk NASH and advanced fibrosis in a large multicentric European cohort
2023 · Vlad Ratziu, Rambabu Surabattula, et al. · Journal of Hepatology
THU-096-Development and validation of true serum biomarkers of liver fibrogenesis ans fibrolysis
2019 · Rambabu Surabattula, Erika Monguzzi, et al. · Journal of Hepatology
Works count: 16
Citation count: 484
H-index: 4
I10-index: 3
Year
Topic
Type